CereHealth subsidiary CereMetrix has released CereMetrixAI, the second generation of its CereMetrix quantitative imaging and reporting platform.
In addition to traditional CereMetrix features such as QSPECT quantitative SPECT image analysis software, the browser-based platform now supports MRI, PET, and CT, as well as nonimaging analytical assessments, according to the vendor. Customers can access these new features via a catalog of in-house and third-party medical image algorithms.
Thanks to improved data collection and reporting capabilities, CereMetrixAI enables broader use of nonimaging assessments such as neuropsychological evaluations and cognitive screens, the company said. As a result, the platform now offers enhanced value in clinical and research applications, according to the firm.
